| Patents for C07J 5 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, and substituted in position 21 by only one singly bound oxygen atom (1,937) |
|---|
| 02/05/2004 | WO2004011663A2 Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids |
| 02/05/2004 | US20040022831 For therapy of mycosis of the nail |
| 01/29/2004 | WO2004009527A1 Materials and methods for treating hypercholesterolemia |
| 01/29/2004 | US20040019023 Administering 9,10-secopregna-5,7,10(19),16- tetraene derivative to a patient for treating skin diseases such as psoriasis |
| 01/29/2004 | CA2492906A1 Materials and methods for treating hypercholesterolemia |
| 01/14/2004 | EP1379542A2 Treatment of tumours |
| 01/08/2004 | US20040006240 Process to prepare 11beta,17alpha ,21-trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-acetate |
| 01/01/2004 | US20040002484 Novel steroidal antiestrogens and antiandrogens and uses thereof |
| 12/31/2003 | WO2003047329A3 Method for the preparation of 6-alpha-fluoro corticosteroids |
| 12/30/2003 | CA2144416C Method and composition for the treatment of hair loss |
| 12/25/2003 | US20030236408 Estrogenic compounds as anti-mitotic agents |
| 12/23/2003 | US6667410 Reducing an alpha-beta-unsaturated ketone to an alpha-hydroxyketone in presence of a catalyst containing manganes complex and a reducing agent |
| 11/27/2003 | WO2003097040A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 11/27/2003 | WO2000062735A3 Treatment of neoplasms with viruses |
| 11/27/2003 | US20030220314 Dehydro-estriol (8-DHE3) and dehydro-pregnanetriol (7-DHPT), and methods of their synthesis |
| 11/27/2003 | US20030220309 17-methylenandrostan-3alpha-ol analogs as CRH inhibitors |
| 11/27/2003 | CA2486141A1 Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases |
| 11/20/2003 | WO2003070745A3 Carbonate and carbamate modified forms of glucocorticoids |
| 11/13/2003 | WO2003092706A1 Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 11/13/2003 | CA2749172A1 Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 11/12/2003 | CN1127333C Local pharmaceutical composition comprising cholinergic agent or calcium channel blocker |
| 11/05/2003 | EP1358883A1 Re-epithelializing pharmaceutical compositions containing xanthan gum |
| 10/30/2003 | WO2003047329A8 Method for the preparation of 6-alpha-fluoro corticosteroids |
| 10/28/2003 | CA2077625C Preparation process of hydrocortisone and novel intermediates |
| 10/23/2003 | US20030199529 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
| 10/21/2003 | CA2072053C 16-methyl substituted steroids derived from pregna 1,4-diene 3,20-dione, their preparation and application to the preparation of 16-methylene steroids and novel intermediate compounds |
| 10/15/2003 | CN1449273A Antimicotic nail varnish composition |
| 10/01/2003 | EP1347744A1 Solid dispersions of nitrate active principles |
| 09/25/2003 | US20030181742 Process for the preparation of pregnane derivatives |
| 09/23/2003 | CA2073760C Steroidal organic substance crystallization method and compounds thereby obtained |
| 09/18/2003 | US20030176407 Carbonate and carbamate modified forms of glucocorticoids |
| 09/17/2003 | EP1344526A1 Preventives/ermedies for inflammatory airway diseases |
| 09/16/2003 | CA2019404C 11 beta-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents |
| 09/09/2003 | US6617319 Animal extracts; uterine contractions; isolation by distillation, flash chromatography |
| 08/28/2003 | WO2003070745A2 Carbonate and carbamate modified forms of glucocorticoids |
| 08/28/2003 | US20030162959 Reacting 17-hydroxy-9 beta ,11 beta -epoxy-16- beta -methyl-pregna-1,4-diene-3,20-dione 21-acetate compound with a stereoselective fluorinating agent to stereoselectively form a 21-ester, 17-hydroxy 6 alpha -fluorinated compound |
| 08/27/2003 | EP1337279A1 Sterilisation of pharmaceuticals |
| 08/27/2003 | EP0988057B1 Bioreductive conjugates for drug targeting |
| 08/26/2003 | US6610674 Method of treating inflammatory conditions with progesterone analogs |
| 08/21/2003 | US20030158167 2-substituted ring A aromatic sterol derivatives having a comparatively short 17-position hydrocarbyl side chain terminates in an carboxaldehyde or hydroxy group; antiproliferative and antiangiogenic agent |
| 08/20/2003 | EP1335928A1 Selective glucocorticoid receptor agonists |
| 08/20/2003 | CN1437610A Oxidation process for preparing the intermediate 6alpha, 9alpha-difluoro-11beta, 17alpha-dihydroxy-16.alpha-methyl-androst-1, 4-dien-3-one-17.Beta-carboxylic acid |
| 08/14/2003 | US20030153545 Methods of making 21-[4'-(nitrooxyalkyl)benzoate] corticosteroid derivatives and intermediates useful in the synthesis thereof |
| 08/14/2003 | US20030153544 Fatty acid derivatives |
| 08/13/2003 | EP1333830A2 Novel medicament compositions based on anticholinergics and corticosteroids |
| 08/13/2003 | CN1436170A Vitamin D derivs. |
| 08/07/2003 | WO2003063859A1 Suppression of cartilage degradation via the estrogen receptor |
| 07/30/2003 | EP1135403B1 17beta-acyl-17alpha-propynyl-11beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/29/2003 | CA2050812C Pregna-1,4-diene-3,20-dione-16-17-acetal-21 esters, process for their preparation, compositions, and methods for the treatment of inflammatory conditions |
| 07/24/2003 | WO2003059931A1 PROCESS FOR THE PREPARATION OF 7α-METHYLSTEROIDS |
| 07/22/2003 | US6596885 19-Nor steroids having a thiocarbonated chain in position 11beta, their preparation process and the intermediates of this process, their use as medicaments and compositions |
| 07/09/2003 | EP1325928A1 Process for the preparation of pregnane derivatives |
| 07/09/2003 | CN1429104A Inhibitors type 5 and type 3 17 beta-hydroxysteroid dehydrogenase and methods for their use |
| 07/01/2003 | CA2089194C Steroid derivatives |
| 06/26/2003 | WO2003051904A1 Process for producing pregnane derivative |
| 06/18/2003 | EP1318816A1 Corticosteroid formulation comprising less than 2.5 mg prednisolone for once daily administration |
| 06/17/2003 | US6579864 Arthritic diseases and/or autoimmune diseases |
| 06/17/2003 | US6579863 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
| 06/12/2003 | WO2003048181A1 17.alpha. -cyclic esters of 16-methylpregnan-3,20-dione as anti-inflammatory agents |
| 06/12/2003 | WO2003047329A2 Method for the preparation of 6-alpha-fluoro corticosteroids |
| 06/12/2003 | CA2473471A1 Method for the preparation of 6-alpha-fluoro corticosteroids |
| 06/05/2003 | US20030103864 Sterilization of pharmaceuticals |
| 05/22/2003 | US20030096800 Estrogenic compounds as anti-mitotic agents |
| 05/14/2003 | EP0830369B1 Nor-pregnanes for inducing hypothalamic effects |
| 05/02/2003 | EP1121375B1 High purity compound (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one |
| 04/30/2003 | CN1414008A Steroid compound containing nitrogen and its preparation method |
| 04/29/2003 | US6555700 1,3-propane diol esters and ethers and methods for their use in drug delivery |
| 04/24/2003 | WO2003010181A8 STEREOSELECTIVE METHOD OF PRODUCING 6α-FLUOROPREGNANES AND INTERMEDIARIES |
| 04/24/2003 | WO2002100437A3 Ophthalmic compositions comprising hyaluronic acid |
| 04/23/2003 | EP1303249A1 Antimycotic nail varnish composition |
| 04/16/2003 | EP1301526A1 Oxidation process for preparing the intermediate 6.alpha.,9.alpha.-difluoro-11.beta.,17.alpha.-dihydroxy-16.alpha.-methyl-androst-1,4-dien-3-one 17.beta.-carboxylic acid |
| 04/15/2003 | CA2084775C Method of treating human prostatic adenocarcinoma |
| 04/01/2003 | US6541463 Inhibitors of type 5 and type 3 17β-hydroxysteroid dehydrogenase and methods for their use |
| 03/26/2003 | EP1295871A1 Vitamin d derivatives |
| 03/20/2003 | US20030055029 Combbretastatin a-4 as an anti-angiogenic agent |
| 03/12/2003 | CN1402734A 3-methylene steroid deriv. |
| 03/06/2003 | WO2003018027A1 Use of pregnane-diones or diols as neuropathic analgesic agents |
| 03/06/2003 | US20030045514 17-Methyleneandrostan-3alpha-ol analogs as CRH inhibitors |
| 03/06/2003 | US20030044885 Process to prepare 11beta, 17alpha,21-trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-acetate |
| 03/06/2003 | CA2468466A1 Use of pregnane-diones or diols as neuropathic analgesic agents |
| 03/05/2003 | EP1288220A2 Neuroactive 3.alpha.-hydroxy-steroids of the androstane and pregnane series |
| 03/05/2003 | EP1287019A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors |
| 03/04/2003 | US6528676 Estrogenic compounds as anti-mitotic agents |
| 03/04/2003 | US6528666 C3 protecting 9,11-epoxy-17,21-dihydroxy-16-methylpregna-1,4-diene-3,20-dione,21-acetate; fluorinating at 6 alpha; depro-tecting and fluorinating epoxy group; simultaneous hydrolysis and oxidative degradation with methanolic potassium hydroxide |
| 02/27/2003 | WO2003015793A1 Delayed and sustained drug release |
| 02/27/2003 | WO2003015791A1 Phophylactic and therapeutic use of hydroxysteroids |
| 02/27/2003 | WO2002058634A3 ESTRADIOL-16α-CARBOXYLIC ACID ESTERS AS LOCALLY ACTIVE ESTROGENS |
| 02/27/2003 | CA2493349A1 Delayed and sustained drug release |
| 02/20/2003 | WO2003014141A1 17alfa, 21-dihydroxypregnene esters as antiandrogenic agents |
| 02/12/2003 | EP0614463B1 Angiostatic steroids |
| 02/06/2003 | WO2003010181A1 STEREOSELECTIVE METHOD OF PRODUCING 6α-FLUOROPREGNANES AND INTERMEDIARIES |
| 02/06/2003 | CA2455229A1 Stereoselective method of producing 6.alpha.-fluoropregnanes and intermediaries |
| 01/30/2003 | US20030023104 For prolonging or altering the activity of a compound which is a member of the chlorambucil family |
| 01/20/2003 | WO2002020552A1 Process for the preparation of pregnane derivatives |
| 01/20/2003 | CA2416850A1 Process for the preparation of pregnane derivatives |
| 01/16/2003 | US20030013900 Process to prepare11beta,17alpha, 21-trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-acetate |
| 01/15/2003 | EP1275379A2 Basic granulate comprising (7 alpha, 17 alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-3-one |
| 01/15/2003 | EP1274409A2 Antiprogestins with partial agonist activity |
| 01/03/2003 | WO2003000696A1 COMBINATION THERAPY OF AN SODm AND A CORTICOSTEROID FOR PREVENTION AND/OR TREATMENT OF INFLAMMATORY DISEASE |
| 01/03/2003 | CA2451602A1 Combination therapy of an sodm and a corticosteroid for prevention and/or treatment of inflammatory disease |